Ateneo de Zamboanga University College of Nursing

Drug Generic Name: Salbutamol Iprafropium Brand Name: (Combivent) Dosage: Route: Nebule Frequency: q8

Mechanism of Action Classification: Bronchodilator Beta2 Adrenergic agonist and anticholinergic Mechanism of Action: Beta2 adrenergic receptor cause bronchodilation and vasodilation Anticholinergic, blocks reflexes by antagonizing action of acetylcholine

Side Effects/ Adverse Effects Fatigue, abdominal pain, hypertension, dyspepsia, tachycardia, sinusitis, dysuria, urinary retention, weakness, edema, vomiting diarrheal constipation

Indication/ Contraindication Indication: Relief and prevention of bronchospasm in patients with airway obstructive disease Bronchodilator

Nursing Responsibilities

Monitor respiratory status, auscultate lungs before and after nebulization Report treatment failure or exacerbation of Contraindication: respiratory Patient with cardiac symptoms to tachyarrythmias, physician hypertropic Do not allow solution obstructive cardiomyopathy and or mist to enter the patient with history of eyes hypersensitivity